U.S. RESEARCH ROUNDUP- Chesapeake Energy, Lucid Diagnostics, Smart Global Holdings

Everbridge

27/12/2021 13:08

Dec 27 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Chesapeake Energy, Lucid Diagnostics and Smart
Global Holdings on Monday. 
    
    HIGHLIGHTS
     * Chesapeake Energy Corp  CHK.O : Siebert Williams initiates with buy rating; PT $90
     * Lucid Diagnostics  LUCD.O : Ascendiant Capital Markets initiates coverage with buy rating
     * Smart Global Holdings Inc  SGH.O : Rosenblatt Securities raises PT to $100 from $75
        
Following is a summary of research actions on U.S. companies reported by Reuters on Monday.
Stock entries are in alphabetical order. 
   
     * Chesapeake Energy Corp  CHK.O : Siebert Williams initiates with buy rating; PT $90
     * Everbridge Inc  EVBG.O : Truist Securities cuts target price to $85 from $185
     * Gamestop Corp  GME.N : Ascendiant Capital Markets cuts target price to $23 from $24
     * Lucid Diagnostics  LUCD.O : Ascendiant Capital Markets initiates coverage with buy rating
     * Lucid Diagnostics  LUCD.O : Ascendiant Capital Markets initiates coverage with $16 PT
     * Medical Properties Trust Inc  MPW.N : Truist Securities raises PT to $25 from $23
     * National Health Investors Inc  NHI.N : Truist Securities cuts target price to $63 from $64
     * Nextplay Technologies Inc  NXTP.O : Ascendiant Capital Markets cuts PT to $5.50 from $6.50
     * Omega Healthcare Investors Inc  OHI.N : Truist Securities cuts PT to $31 from $36
     * Ortho Clinical Diagnostics Holdings Plc  OCDX.O : H.C. Wainwright cuts to neutral from buy
     * Sabra Health Care REIT  SBRA.O : Truist Securities cuts target price to $16 from $18
     * Smart Global Holdings Inc  SGH.O : Rosenblatt Securities raises PT to $100 from $75
 

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))